Document is current
Any future updates will be listed below
-
Authors
Kucha, Piotr https://orcid.org/0000-0003-0664-159X
Rawa, Tomasz https://orcid.org/0000-0001-6762-4481
Kiljan, Jakub
Zagórowicz, Edyta https://orcid.org/0000-0003-3488-2593
- License Information
-
More Information
Article History
Received: 20 August 2025
Accepted: 5 September 2025
First Online: 13 September 2025
Declarations
:
: Piotr Kucha received speaker fees from Pfizer and Abbvie and travel grants from Janssen and Takeda. Tomasz Rawa received speaker fees from BMS and Polpharma and a travel grant from Recordati. Jakub Kiljan has nothing to declare. Edyta Zagórowicz received speaker fees from Abbvie, Eli Lilly, Bristol Myers Squibb, Takeda, and Janssen, and consultancy or advisory board member fees from Janssen, Eli Lilly. The authors declare no competing interests.
: The patient’s informed consent was obtained to present her case.
